{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:53:29Z","timestamp":1789977209039,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s11882-013-0416-2","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T06:57:19Z","timestamp":1389769039000},"source":"Crossref","is-referenced-by-count":33,"title":["Efficacy and Safety of Long-Term Antibiotics (Macrolides) for the Treatment of Chronic Rhinosinusitis"],"prefix":"10.1007","volume":"14","author":[{"given":"Anders","family":"Cervin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Wallwork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"416_CR1","first-page":"254","volume":"22","author":"S Kudoh","year":"1984","unstructured":"Kudoh S, Kimura H, Uetake T, et al. Clinical effect of low-dose, long-term macrolide antibiotic chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis. 1984;22:254\u20134.","journal-title":"Jpn J Thorac Dis"},{"issue":"10","key":"416_CR2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00005537-200210000-00022","volume":"112","author":"B Wallwork","year":"2002","unstructured":"Wallwork B, Coman W, Feron F, Mackay-Sim A, Cervin A. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope. 2002;112(10):1827\u201330.","journal-title":"Laryngoscope"},{"issue":"2","key":"416_CR3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00005537-200402000-00019","volume":"114","author":"B Wallwork","year":"2004","unstructured":"Wallwork B, Coman W, Mackay-Sim A, Cervin A. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope. 2004;114(2):286\u201390.","journal-title":"Laryngoscope"},{"issue":"12 Pt 1","key":"416_CR4","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/00005537-199712000-00016","volume":"107","author":"H Suzuki","year":"1997","unstructured":"Suzuki H, Shimomura A, Ikeda K, Furukawa M, Oshima T, Takasaka T. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope. 1997;107(12 Pt 1):1661\u20136.","journal-title":"Laryngoscope"},{"issue":"6","key":"416_CR5","first-page":"554","volume":"45","author":"T Nakajima","year":"1996","unstructured":"Nakajima T, Yoshizawa I, Kawano Y, Noma T. [Suppressive effect of roxithromycin on the induction of IL-2 responsiveness by DF-stimulated lymphocytes from patients with bronchial asthma]. [Japanese]. Arerugi Jpn J Allergol. 1996;45(6):554\u201361.","journal-title":"Arerugi Jpn J Allergol"},{"issue":"2","key":"416_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijporl.2006.10.016","volume":"71","author":"Y Ishida","year":"2007","unstructured":"Ishida Y, Abe Y, Harabuchi Y. Effects of macrolides on antigen presentation and cytokine production by dendritic cells and T lymphocytes. Int J Pediatr Otorhinolaryngol. 2007;71(2):297\u2013305.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2 Suppl","key":"416_CR7","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1378\/chest.125.2_suppl.41S","volume":"125","author":"J Tamaoki","year":"2004","unstructured":"Tamaoki J. The effects of macrolides on inflammatory cells. Chest. 2004;125(2 Suppl):41S\u201350S. quiz 1S.","journal-title":"Chest"},{"issue":"4","key":"416_CR8","doi-asserted-by":"crossref","first-page":"L565","DOI":"10.1152\/ajplung.00316.2004","volume":"289","author":"K Ishizawa","year":"2005","unstructured":"Ishizawa K, Suzuki T, Yamaya M, Jia YX, Kobayashi S, Ida S, et al. Erythromycin increases bactericidal activity of surface liquid in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;289(4):L565\u201373.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"416_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1164\/rccm.200711-1666OC","volume":"178","author":"S Hodge","year":"2008","unstructured":"Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, et al. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respirator Crit Care Med. 2008;178(2):139\u201348.","journal-title":"Am J Respirator Crit Care Med"},{"issue":"3","key":"416_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2500\/105065800782102717","volume":"14","author":"T Yamada","year":"2000","unstructured":"Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol. 2000;14(3):143\u20138.","journal-title":"Am J Rhinol"},{"issue":"2","key":"416_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.mlg.0000191560.53555.08","volume":"116","author":"B Wallwork","year":"2006","unstructured":"Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006;116(2):189\u201393.","journal-title":"Laryngoscope"},{"issue":"1","key":"416_CR12","first-page":"66","volume":"47","author":"S Haruna","year":"2009","unstructured":"Haruna S, Shimada C, Ozawa M, Fukami S, Moriyama H. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. Rhinology. 2009;47(1):66\u201371.","journal-title":"Rhinology"},{"issue":"3","key":"416_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000027731","volume":"62","author":"H Suzuki","year":"2000","unstructured":"Suzuki H, Ikeda K, Honma R, Gotoh S, Oshima T, Furukawa M, et al. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec. 2000;62(3):121\u20137.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"5","key":"416_CR14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00005537-200405000-00027","volume":"114","author":"SM Ragab","year":"2004","unstructured":"Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope. 2004;114(5):923\u201330.","journal-title":"Laryngoscope"},{"issue":"6","key":"416_CR15","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.2500\/ajra.2011.25.3728","volume":"25","author":"M Zeng","year":"2011","unstructured":"Zeng M, Long XB, Cui YH, Liu Z. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. Am J Rhinol Allerg. 2011;25(6):e203\u20137.","journal-title":"Am J Rhinol Allerg"},{"issue":"10","key":"416_CR16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1398-9995.2011.02637.x","volume":"66","author":"L Ba","year":"2011","unstructured":"Ba L, Zhang N, Meng J, Zhang J, Lin P, Zhou P, et al. The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps. Allergy. 2011;66(10):1296\u2013303.","journal-title":"Allergy"},{"issue":"4","key":"416_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2500\/ajra.2012.26.3778","volume":"26","author":"RS Jiang","year":"2012","unstructured":"Jiang RS, Wu SH, Tsai CC, Li YH, Liang KL. Efficacy of Chinese herbal medicine compared with a macrolide in the treatment of chronic rhinosinusitis without nasal polyps. Am J Rhinol Allerg. 2012;26(4):293\u20137.","journal-title":"Am J Rhinol Allerg"},{"issue":"4","key":"416_CR18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000328342","volume":"73","author":"Q Luo","year":"2011","unstructured":"Luo Q, Chen F, Liu W, Li Z, Xu R, Fan Y, et al. Evaluation of long-term clarithromycin treatment in adult Chinese Patients with chronic rhinosinusitis without nasal polyps. ORL J Otorhinolaryngol Relat Spec. 2011;73(4):206\u201311.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"1","key":"416_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.anl.2011.04.015","volume":"39","author":"Y Majima","year":"2012","unstructured":"Majima Y, Kurono Y, Hirakawa K, Ichimura K, Haruna S, Suzaki H, et al. Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. Auris Nasus Larynx. 2012;39(1):38\u201347. This open study has a high number of patients, n = 425 and uses the validated SNOT-20 for evaluation.","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"416_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4193\/Rhino11.123","volume":"50","author":"WJ Videler","year":"2012","unstructured":"Videler WJ, van Hee K, Reinartz SM, Georgalas C, van der Meulen FW, Fokkens WJ. Long-term low-dose antibiotics in recalcitrant chronic rhinosinusitis: a retrospective analysis. Rhinology. 2012;50(1):45\u201355. Analyses of other long-term antibiotics.","journal-title":"Rhinology"},{"issue":"4","key":"416_CR21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.anl.2012.09.009","volume":"40","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y, Suzuki M, Yokota M, Ozaki S, Ohno N, Hamajima Y, et al. Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery. Auris Nasus Larynx. 2013;40(4):366\u201372.","journal-title":"Auris Nasus Larynx"},{"issue":"5","key":"416_CR22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1067\/mhn.2002.124849","volume":"126","author":"A Cervin","year":"2002","unstructured":"Cervin A, Kalm O, Sandkull P, Lindberg S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol\u2013Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg. 2002;126(5):481\u20139.","journal-title":"Otolaryngol\u2013Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg"},{"key":"416_CR23","first-page":"73","volume":"525","author":"M Hashiba","year":"1996","unstructured":"Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl (Stockh). 1996;525:73\u20138.","journal-title":"Acta Otolaryngol Suppl (Stockh)."},{"issue":"5","key":"416_CR24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S0022215112000485","volume":"126","author":"A Peric","year":"2012","unstructured":"Peric A, Vojvodic D, Matkovic-Jozin S. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the 'regulated on activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis. J Laryngol Otol. 2012;126(5):495\u2013502.","journal-title":"J Laryngol Otol"},{"issue":"6","key":"416_CR25","first-page":"359","volume":"51","author":"P Dabirmoghaddam","year":"2013","unstructured":"Dabirmoghaddam P, Mehdizadeh Seraj J, Bastaninejad S, Meighani A, Mokhtari Z. The efficacy of clarithromycin in patients with severe nasal polyposis. Acta Med Iran. 2013;51(6):359\u201364.","journal-title":"Acta Med Iran"},{"issue":"11","key":"416_CR26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1398-9995.2011.02693.x","volume":"66","author":"WJ Videler","year":"2011","unstructured":"Videler WJ, Badia L, Harvey RJ, Gane S, Georgalas C, van der Meulen FW, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66(11):1457\u201368. One of only two placebo-controlled trials. This was a mixed group of CRS patients and no significant treatment effect was seen.","journal-title":"Allergy"},{"issue":"23","key":"416_CR27","first-page":"1","volume":"3","author":"WJ Fokkens","year":"2012","unstructured":"Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;3(23):1\u2013298. An important reference paper.","journal-title":"Rhinol Suppl"},{"issue":"8","key":"416_CR28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"RK Albert","year":"2011","unstructured":"Albert RK, Connett J, Bailey WC, Casaburi R, Cooper Jr JA, Criner GJ, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365(8):689\u201398.","journal-title":"N Engl J Med"},{"issue":"4","key":"416_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","volume":"50","author":"JF Westphal","year":"2000","unstructured":"Westphal JF. Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. Brit J Clin Pharmacol. 2000;50(4):285\u201395.","journal-title":"Brit J Clin Pharmacol"},{"issue":"Suppl H","key":"416_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jac\/16.suppl_A.181","volume":"16","author":"D Pessayre","year":"1985","unstructured":"Pessayre D, Larrey D, Funck-Brentano C. Drug interactions and hepatitis produced by some macrolide antibiotics. J Antimicrob Chemother. 1985;16(Suppl H):181\u201394.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"416_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000137958","volume":"28","author":"K Bachmann","year":"1984","unstructured":"Bachmann K, Schwartz JI, Forney Jr R, Frogameni A, Jauregui LE. The effect of erythromycin on the disposition kinetics of warfarin. Pharmacology. 1984;28(3):171\u20136.","journal-title":"Pharmacology"},{"issue":"4","key":"416_CR32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199607253350416","volume":"335","author":"DK Wysowski","year":"1996","unstructured":"Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med. 1996;335(4):290\u20131.","journal-title":"N Engl J Med"},{"issue":"5","key":"416_CR33","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0009-9236(96)90179-4","volume":"59","author":"N Yasui","year":"1996","unstructured":"Yasui N, Otani K, Kaneko S, Ohkubo T, Osanai T, Sugawara K, et al. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism. Clin Pharmacol Ther. 1996;59(5):514\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"416_CR34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archinte.1996.00440060103013","volume":"156","author":"LG Cohen","year":"1996","unstructured":"Cohen LG, Chesley S, Eugenio L, Flood JG, Fisch J, Goff DC. Erythromycin-induced clozapine toxic reaction. Archiv Inter Med. 1996;156(6):675\u20137.","journal-title":"Archiv Inter Med"},{"issue":"3","key":"416_CR35","first-page":"1203","volume":"22","author":"GC Yee","year":"1990","unstructured":"Yee GC. Pharmacokinetic interactions between cyclosporine and other drugs. Transplant Proc. 1990;22(3):1203\u20137.","journal-title":"Transplant Proc"},{"issue":"2","key":"416_CR36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00002018-199513020-00005","volume":"13","author":"NA Rosensteil von","year":"1995","unstructured":"von Rosensteil NA, Adam D. Macrolide antibacterials. Drug interactions of clinical significance. Drug Saf: Int J Med Toxicol Drug Exp. 1995;13(2):105\u201322.","journal-title":"Drug Saf: Int J Med Toxicol Drug Exp"},{"key":"416_CR37","first-page":"234","volume":"93","author":"N Yumibe","year":"1994","unstructured":"Yumibe N, Huie K, Chen K, Clement R, Caten M. Identification of human liver cytochrome P450s involved in the microsomal metabolism of the antihistaminic drug loratadine (Abstract). J Allergy Clin Immunol. 1994;93:234\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"416_CR38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-158-12-201306180-00004","volume":"158","author":"AM Patel","year":"2013","unstructured":"Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, et al. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Inter Med. 2013;158(12):869\u201376.","journal-title":"Ann Inter Med"},{"issue":"20","key":"416_CR39","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366(20):1881\u201390.","journal-title":"N Engl J Med"},{"issue":"18","key":"416_CR40","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJMp1302726","volume":"368","author":"AD Mosholder","year":"2013","unstructured":"Mosholder AD, Mathew J, Alexander JJ, Smith H, Nambiar S. Cardiovascular risks with azithromycin and other antibacterial drugs. N Engl J Med. 2013;368(18):1665\u20138.","journal-title":"N Engl J Med"},{"key":"416_CR41","doi-asserted-by":"crossref","first-page":"f1235","DOI":"10.1136\/bmj.f1235","volume":"346","author":"S Schembri","year":"2013","unstructured":"Schembri S, Williamson PA, Short PM, Singanayagam A, Akram A, Taylor J, et al. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies. BMJ. 2013;346:f1235. The most recent report in a large cohort, suggsting an increased risk of about 1.6.","journal-title":"BMJ"},{"issue":"5","key":"416_CR42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2165\/00002018-199309050-00004","volume":"9","author":"P Periti","year":"1993","unstructured":"Periti P, Mazzei T, Mini E, Novelli A. Adverse effects of macrolide antibacterials. Drug Saf: Int J Med Toxic Drug Exp. 1993;9(5):346\u201364.","journal-title":"Drug Saf: Int J Med Toxic Drug Exp"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-013-0416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-013-0416-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-013-0416-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T16:09:48Z","timestamp":1648051788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-013-0416-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s11882-013-0416-2","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]},"article-number":"416"}}